Beyond the Hype: PERDOSKI Addresses the Controversy Surrounding South Korean "Corpse Skin" Skin Boosters in Indonesia

JAKARTA — The Indonesian Association of Dermatology and Venereology Specialists (PERDOSKI) has officially addressed the viral beauty trend surrounding skin booster treatments containing Human Acellular Dermal Matrix (hADM)—widely sensationalized across social media as "corpse skin" injections. Originating from South Korea, this aesthetic procedure has sparked intense public debate and curiosity regarding its raw materials and safety profile.

While the trend has gained traction among beauty enthusiasts looking for advanced anti-aging and skin regeneration solutions, medical professionals urge caution, emphasizing that the nomenclature used by the public creates unnecessary alarm while masking deeper regulatory and scientific questions.

Main Facts: What is hADM and the "Corpse Skin" Trend?

The core controversy revolves around Human Acellular Dermal Matrix (hADM), a biological material utilized in advanced tissue engineering.

• The Source Material: hADM is derived from human donor tissue. However, the exact provenance—whether harvested from living donors or cadavers—remains a point of ambiguity for international observers and local medical associations alike.
• The Aesthetic Application: In South Korea’s highly competitive beauty and dermatology market, hADM has been processed into injectable formulations marketed as high-end skin boosters designed to promote collagen production, improve skin elasticity, and accelerate tissue repair.
• The Medical Reality: Historically and globally, acellular dermal matrices have played a crucial role in reconstructive surgery—such as treating severe burn victims, assisting in breast reconstruction post-mastectomy, and repairing complex periodontal defects. Their adaptation into routine cosmetic dermatology is a relatively recent phenomenon.
• The Indonesian Context: PERDOSKI has confirmed that these specific hADM-based skin boosters have not been approved for widespread aesthetic use in Indonesia. The association stresses that before any such product can enter the domestic market, it must pass rigorous safety evaluations, ethical clearances, and legal compliance checks set by the Indonesian Ministry of Health and the Indonesian Food and Drug Authority (BPOM).

Chronology of the Controversy

The journey of the "corpse skin" trend from niche South Korean dermatological clinics to mainstream Indonesian social media discourse unfolded through several key phases:

1. Emergence in South Korean Aesthetics (Late 2023 – 2024): Advanced biotech firms in South Korea began introducing processed human tissue matrices into the cosmetic sphere, promoting them as the next frontier in regenerative anti-aging medicine, moving beyond traditional hyaluronic acid fillers and platelet-rich plasma (PRP).
2. Viral Sensationalism on Social Media (2025): As medical aesthetic tourism brought Indonesian influencers and patients to Seoul, procedures utilizing hADM products began appearing in vlogs and TikTok reviews. Due to translation nuances and sensationalized headlines, foreign media and local content creators dubbed the treatment suntik kulit mayat ("corpse skin injections").
3. Public Scrutiny and Ethical Concerns (Early 2026): The dramatic moniker ignited widespread ethical debates across Indonesian digital spaces. Questions regarding religious compliance, consent of donors, and potential transmission of pathogens dominated public discourse.
4. PERDOSKI’s Official Intervention (September 2026): Prompted by rising patient inquiries and consumer confusion, PERDOSKI Central leadership stepped forward to clarify the medical facts, debunk misconceptions, and outline the strict regulatory hurdles facing the controversial product class.

Supporting Data and Medical Context

To understand why the medical community is treading carefully, one must examine the science behind Human Acellular Dermal Matrix (hADM) and how it compares to conventional dermatological treatments.

How hADM Works

Human Acellular Dermal Matrix is essentially human skin tissue that has undergone a decellularization process—a complex multi-step laboratory procedure designed to strip away all cellular components (such as epidermal cells and fibroblasts) while preserving the extracellular matrix (ECM), which is rich in collagen, elastin, and vascular channels.

• Biocompatibility: Because the cellular material (which triggers immune rejection) is removed, hADM acts as a biocompatible scaffold. When introduced into a recipient’s body, host cells gradually migrate into the matrix, laying down new tissue and blood vessels.
• The Scientific Gap: While hADM’s efficacy in reconstructive surgery is well-documented in peer-reviewed surgical literature, Dr. Dr. Hanny Nilasari, Sp.DVE, Subsp.Ven, FINSDV, FAADV, Chairperson of PERDOSKI Central, notes a distinct lack of transparent, publicly available clinical trials regarding its specific use in micro-dosed aesthetic skin boosters.
• The Processing Mystery: "So, regarding the technical aspects, we truly do not understand them yet," Dr. Hanny stated during an exclusive interview with detikcom on Wednesday, September 16, 2026. "There are no open scientific publications comprehensively detailing the precise harvesting and processing techniques used for these specific cosmetic formulations."

Traditional vs. Regenerative Aesthetics

Official Responses from PERDOSKI

The stance of the Indonesian Association of Dermatology and Venereology Specialists is rooted in three foundational pillars: Patient Safety (Patient Sefety), Legal Certainty, and Scientific Transparency.

1. Debunking the "Corpse Skin" Misnomer

Dr. Hanny clarified that while the raw material originates from human tissue donors, labeling the treatment casually as a "corpse skin injection" is medically inaccurate and sensationalist.

"So, (it is made from) a skin tissue matrix originating from a donor. But the donor itself—we do not know for sure whether it is a living donor or a deceased donor," Dr. Hanny explained. "However, the term ‘corpse skin injection’ does not accurately reflect the actual reality of the product’s processed state."

2. The Strict Criteria for Indonesian Market Entry

PERDOSKI emphasized that Indonesia possesses rigorous regulatory frameworks overseen by health authorities to protect consumers from unverified medical interventions. For any human tissue-derived cosmetic product to be legally imported, distributed, and administered in Indonesia, it must clear multiple bureaucratic and scientific checkpoints:

• Ethical Clearances: Clear documentation regarding the ethical sourcing of human tissues, ensuring informed consent from donors or their families, compliant with international bioethical standards.
• Pathogen Safety: Absolute scientific proof that the decellularization and sterilization processes completely eradicate risks of viral, bacterial, or prion transmission.
• Clinical Evidence: Randomized controlled trials demonstrating superior efficacy and safety profiles compared to existing, approved aesthetic modalities.
• Legal Transparency: Full disclosure of manufacturing origins, supply chain logistics, and regulatory approvals from country-of-origin health agencies (such as South Korea’s Ministry of Food and Drug Safety).

"If all of those requirements have been fulfilled, perhaps then we can evaluate whether or not it can be approved for entry into Indonesia," Dr. Hanny concluded.

Implications for Patients, Practitioners, and the Beauty Industry

The debate surrounding hADM skin boosters carries significant ramifications across various sectors of Indonesia’s booming health and beauty ecosystem.

For Consumers and Patients

• Heightened Skepticism: Patients are becoming increasingly critical of trends imported from abroad, learning to differentiate between viral social media marketing and evidence-based medicine.
• Safety Awareness: The controversy serves as a vital reminder that aesthetic procedures—even those performed minimally via injections—involve biological interactions that carry inherent risks if products are unvetted. Consumers are strongly advised to consult board-certified dermatologists (Sp.DVE) rather than seeking treatments at unlicensed clinics offering unregulated imported products.

For Aesthetic Practitioners and Clinics

• Compliance Pressure: Ethical aesthetic clinics in Indonesia must exercise extreme caution. Utilizing black-market or smuggled South Korean hADM products exposes practitioners to severe legal penalties, license revocation, and malpractice lawsuits.
• The Burden of Proof: Dermatologists are reminded to rely strictly on products registered with the Indonesian Ministry of Health and BPOM, steering clear of experimental treatments lacking robust local clinical backing.

For the Domestic and Regional Beauty Market

• Regulatory Vigilance: BPOM and related health agencies are likely to increase surveillance on cross-border medical tourism and online cosmetic product smuggling, particularly targeting niche biological injectables.
• Industry Standards: The incident highlights the growing convergence between advanced regenerative medicine and aesthetic dermatology, signaling that future beauty trends will require much tighter collaboration between biotech innovators and medical regulatory bodies.

Conclusion

The fascination with South Korean hADM skin boosters—popularly dubbed "corpse skin injections"—illustrates the fast-paced, boundary-pushing nature of modern global aesthetics. However, as PERDOSKI has firmly established, clinical enthusiasm must never outpace scientific verification and patient safety.

Until comprehensive clinical trials, transparent sourcing data, and official regulatory clearances are thoroughly established, these biological matrices will remain confined to the realm of advanced reconstructive medicine rather than finding a place on Indonesian cosmetic clinic shelves. Patients are urged to prioritize safety, legality, and professional medical consultation above viral internet beauty trends.